ÂÜÀòÂÒÂ×

Cristina Csimma is a seasoned biopharmaceutical executive and board director, currently serving on the boards of Gesynta Pharma AB, Syncona Limited, and Asgard Therapeutics. They have held various leadership roles, including Vice President of Drug Development at Virdante Pharmaceuticals and Senior Director at Wyeth Research. Cristina's extensive experience also includes being a member of scientific advisory boards, such as those for the Muscular Dystrophy Association and CureDuchenne. They are continuously pursuing advanced studies in research methodology at Northeastern University and pharmacy at the Massachusetts College of Pharmacy and Health Sciences.